What’s behind Indian pharma cos’ global acquisition spree
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
gland pharma company
December 2022
October 2022
Gland Pharma hits 52-week low; Here’s why
Over the past 10 months, the pharmaceutical firm's stock has fallen more than 58%.
This largecap stock falls 15% on weak Q2 results; down 50% YTD
The pharma stock touched an all-time low of ₹1,891 on the BSE on Thursday after it reported disappointing earnings in the September quarter.
